Callahan Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.08M Sell
53,216
-3,576
-6% -$343K 0.38% 60
2026
Q1
$5.89M Buy
56,792
+25,228
+80% +$2.86M 0.49% 52
2025
Q4
$3.18M Buy
+31,564
New +$3.43M 0.26% 72
2022
Q1
Sell
-1,256
Closed -$219K 147
2021
Q4
$219K Buy
1,256
+1
+0.1% +$167 0.02% 145
2021
Q3
$208K Buy
1,255
+32
+3% +$5.51K 0.03% 141
2021
Q2
$220K Buy
1,223
+101
+9% +$18.4K 0.03% 142
2021
Q1
$216K Sell
1,122
-50
-4% -$9.63K 0.03% 136
2020
Q4
$237K Sell
1,172
-108
-8% -$22.3K 0.03% 132
2020
Q3
$269K Buy
1,280
+1
+0.1% +$223 0.04% 123
2020
Q2
$281K Sell
1,279
-7,150
-85% -$1.43M 0.05% 111
2020
Q1
$1.46M Buy
8,429
+22
+0.3% +$3.63K 0.31% 68
2019
Q4
$1.29M Buy
8,407
+3
+0% +$448 0.21% 78
2019
Q3
$1.28M Buy
8,404
+3
+0% +$474 0.22% 76
2019
Q2
$1.29M Buy
8,401
+2
+0% +$306 0.23% 76
2019
Q1
$1.35M Buy
8,399
+399
+5% +$61.9K 0.25% 74
2018
Q4
$1.23M Hold
8,000
0.26% 74
2018
Q3
$1.2M Sell
8,000
-100
-1% -$14.2K 0.22% 81
2018
Q2
$1.1M Hold
8,100
0.22% 79
2018
Q1
$1.08M Hold
8,100
0.22% 80
2017
Q4
$1.21M Hold
8,100
0.24% 76
2017
Q3
$1.07M Hold
8,100
0.22% 79
2017
Q2
$1.08M Hold
8,100
0.23% 77
2017
Q1
$1.09M Hold
8,100
0.25% 74
2016
Q4
$972K Sell
8,100
-200
-2% -$23.6K 0.23% 77
2016
Q3
$1.04M Hold
8,300
0.26% 71
2016
Q2
$1.15M Hold
8,300
0.3% 65
2016
Q1
$1.05M Hold
8,300
0.29% 64
2015
Q4
$1.05M Hold
8,300
0.3% 67
2015
Q3
$959K Hold
8,300
0.29% 69
2015
Q2
$863K Hold
8,300
0.25% 80
2015
Q1
$916K Hold
8,300
0.27% 77
2014
Q4
$865K Hold
8,300
0.25% 79
2014
Q3
$797K Hold
8,300
0.25% 82
2014
Q2
$759K Hold
8,300
0.24% 84
2014
Q1
$730K Hold
8,300
0.25% 82
2013
Q4
$770K Buy
8,300
+1,000
+14% +$90.1K 0.27% 80
2013
Q3
$597K Hold
7,300
0.23% 82
2013
Q2
$607K Buy
+7,300
New +$628K 0.25% 80

Other funds holding CLX

Callahan Advisors's CLX Position: Q2 2026 in Review

Callahan Advisors reduced its Clorox (CLX) stake by 6.3% in Q2 2026, selling an estimated $343K and leaving 53,216 shares worth $5.08M. The position accounts for 0.38% of the portfolio, ranked #60.

Callahan Advisors first reported a position in CLX in Q2 2013 and has held it in 38 quarters since. The position peaked at $5.89M in Q1 2026. 463 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Callahan Advisors held 53,216 shares of Clorox worth $5.08M as of Q2 2026.
  • Callahan Advisors sold 3,576 Clorox shares in Q2 2026, an estimated $343K.
  • Clorox made up 0.38% of Callahan Advisors's portfolio in Q2 2026, its #60 holding.
  • Callahan Advisors first reported a position in Clorox in Q2 2013 and has held it in 38 quarters since.
  • Callahan Advisors's Clorox position peaked at $5.89M in Q1 2026.
  • 463 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Callahan Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.